TABLE 3.
The hazards for histological type, stage and RT indication for OS and PFS
| Median OS (months) | Adjusted HR (CI95%) for OS | Median PFS (months) | Adjusted HR (CI95%) for PFS | ||
|---|---|---|---|---|---|
| RT category | Definitive (Unresectable Primary) | 26 | Ref. | 25 | Ref. |
| Adjuvant Primary | Not reached | 0.7 (0.08–6.25) | 22 | 1.5 (0.25–9.45) | |
| Salvage (Unresectable Primary) | 26 | 1.6 (0.11–23.30) | 16 | 5.5 (0.72–41.48) | |
| Palliative | 28 | 5.6 (0.30–102.88) | 15 | 6.9 (0.67–73.84) | |
| Stage | IVA | 26 | Ref. | 18.6 | Ref. |
| IVB | 44 | 0.4 (0.09–2.15) | 22 | 1.1 (0.38–3.68) | |
| IVC | 29 | 0.1 (0.01–2.00) | 21 | 0.4 (0.06–2.69) | |
| Histological type | Differentiated | 29 | Ref. | 23 | Ref. |
| Poorly‐differentiated or Undifferentiated | Not reached | 0.8 (0.16–3.53) | 12 | 1.4 (0.47–4.22) | |
| MTC | 40.5 | 0.5 (0.09–3.32) | 26 | 0.6 (0.17–2.43) |